Spain
Distributor of Grifols-branded products, serving as a stable gateway for international manufacturers entering Taiwan.
With Taiwan as our headquarters and distribution hub, we have built three strategic axes — import, export and business development:
distributing quality products from international manufacturers in Spain, the United States, Germany and other countries; exporting our contract-manufactured Urokinase to Asia-Pacific markets such as Hong Kong, Singapore and Malaysia; and continuing to explore new cooperation opportunities in Japan and other regions.
Every partnership we build centres on patient medication safety, forming a green network of life that spans three continents.
Distributor of Grifols-branded products, serving as a stable gateway for international manufacturers entering Taiwan.
Distributor of Grifols-branded products, serving as a stable gateway for international manufacturers entering Taiwan.
Project-based import cooperation with a German manufacturer, establishing a stable supply relationship.
Import cooperation with a French manufacturer, establishing a stable supply relationship.
Home to our headquarters, leading the global distribution of Urokinase 60,000 IU and bringing a range of international brands into the Taiwan market.
A key export market for our contract-manufactured Urokinase, and the pivotal starting point for the brand's entry into Greater China.
An important Southeast Asian market that plays a steady role in our Asia-Pacific export footprint.
An important Southeast Asian market that plays a steady role in our Asia-Pacific export footprint.
A key market in our southbound strategy, where cooperation across Southeast Asia continues to deepen.
Launched in Thailand in 2013, strengthening brand visibility across Southeast Asia.
An important Southeast Asian market and an early presence in an emerging market.